Retrieve Medical Holdings, Inc. (RMHI)

Retrieve Medical Holdings is a healthcare software company focused on a specific problem: emergency department clinicians do not always have a complete picture of a patient’s medical history at the moment they need to make a treatment decision. The company builds software tools that pull together fragmented medical records, highlight relevant clinical information, and offer decision-support prompts to help emergency physicians and nurses make faster, more informed decisions during a crisis.

The company is smaller than the dominant electronic health record vendors (Epic, Cerner, Allscripts) and operates in a narrower niche—emergency medicine rather than the full hospital or ambulatory system. This focus is both strength and constraint: the company can build depth in its domain, but it depends on emergency departments choosing to buy and integrate a specialist tool alongside their broader EHR systems. The addressable market is fragmented, and competition is stiff.

Retrieve Dx/MDM — clinical decision support for acute care

The company’s flagship product is Retrieve Dx/MDM, a clinical decision-support application designed for emergency departments. When a patient arrives in the ED, clinicians have minutes to decide whether the patient needs imaging, advanced diagnostics, admission, or discharge. Complete information matters—a prior diagnosis of pulmonary embolism, an allergy, a surgical history—but that information is scattered across different hospitals’ EHR systems, urgent-care records, and pharmacy databases.

Retrieve Dx/MDM performs an intelligent search of a patient’s accumulated medical records and lab results, then surfaces the most relevant information to the treating clinician. The software uses natural language processing to extract structured data from unstructured notes, reducing the time clinicians spend hunting for critical history. Hospitals pay a subscription fee per ED visit or per deployed license. The selling proposition is straightforward: better information faster leads to better clinical outcomes and, potentially, reduces unnecessary testing.

The software competes against manual chart review, generic medical search engines, and larger EHR vendors’ built-in search tools. Many hospitals tolerate poor visibility into prior medical history because integrating specialty software requires IT investment and ongoing maintenance. Retrieve Medical must convince hospital IT and ED leadership that the added specificity and speed justify the cost and integration effort.

Retrieve GED — elder abuse and dementia screening

A second product line, Retrieve GED, focuses on a different ED problem: screening for dementia, delirium, agitation, elder abuse, and social determinants of health in elderly patients presenting to the emergency department. The software flags risk factors and prompts clinicians to ask structured assessment questions, similar to how EHRs prompt screening for depression or fall risk.

This product addresses a genuine gap. Emergency departments often miss elder abuse, misdiagnose dementia-related confusion as acute delirium, and overlook social factors—homelessness, isolation, financial hardship—that drive ED utilisation. Identifying these issues in the acute setting opens pathways to case management, social work, and community resources. The clinical benefit is clear; the adoption challenge is whether overworked ED staff will consistently use another software tool.

The two products—Retrieve Dx/MDM and Retrieve GED—serve partially overlapping customer bases (emergency departments) but address different clinical needs. Both require integration with the hospital’s EHR and often with external data sources like pharmacy networks and prior hospital records. Both generate recurring subscription revenue if implemented successfully.

Retrieve Passport — consumer medical records

In 2024–2026, Retrieve Medical launched Retrieve Passport, a direct-to-consumer platform. Passport allows individuals to access, organize, and share their complete medical records in one digital location, with portability across healthcare systems. The pitch is convenience and agency: patients gain a unified view of their fragmented records and can grant access to clinicians, family members, or other services.

Passport represents a shift in business model and product philosophy. Rather than selling solely to hospital systems, the company is building a consumer-facing platform that could generate revenue from subscriptions, data partnerships, or integration with insurance companies’ care-coordination platforms. It also opens a feedback loop: if patients have complete records and share them with ED clinicians, the use of the Retrieve Dx/MDM clinical tool becomes more valuable.

The commercial viability of Retrieve Passport depends on adoption. Healthcare record portability is increasingly required by regulation (HIPAA, the 21st Century Cures Act), and patients are being offered free record-access tools by their health systems and insurers. Retrieve Passport must differentiate on ease of use, security, and portability across many different EHRs—a difficult technical problem. If successful, it could become a significant revenue driver. If it remains a niche app among patients already interested in health optimization, it will not move the financial needle.

Revenue model and scale challenges

Retrieve Medical’s revenue comes from licensing software to hospitals and health systems on a subscription basis, often bundled with implementation services and support. The company is profitable at the product level but operates at relatively small scale—estimated market cap in the 27 million dollar range and a few hundred customer institutions at most, compared to Epic’s thousands of health systems.

Scaling healthcare software is difficult. Each customer integration is custom; training is required; clinical buy-in is essential. The sales cycle is long. Retrieve Medical competes against larger, more established vendors who can offer integrated suites of tools, dedicated implementation teams, and deeper integration with existing customer infrastructure. The advantage of a specialist vendor is focus and domain depth; the disadvantage is that hospital IT departments prefer to consolidate vendors and reduce integration complexity.

Revenue growth depends on three levers: acquiring new ED customer hospitals, expanding usage within existing customers (more EDs per hospital, more users per ED), and launching new products or adjacent applications. The Passport consumer platform is a new lever; whether it drives meaningful revenue growth will likely determine the company’s trajectory.

Financial constraints and market position

Retrieve Medical is a micro-cap stock with minimal analyst coverage and limited institutional investment. Access to capital is constrained compared to larger software companies. This limits the company’s ability to fund aggressive sales expansion, product development, or acquisitions. The company must operate lean and demonstrate unit economics (revenue per customer, gross margin) sufficient to support growth without burning cash.

The absence of positive unit economics would be a death knell; the company would eventually exhaust capital and be forced to sell, merge, or shut down. The presence of positive unit economics but slow growth is a viable but unglamorous position: the company remains solvent, generates modest returns for shareholders, but does not capture significant value or market share.

How a reader would research this

Start with the company’s SEC filings (10-K and 10-Q). Look for revenue by product line and by customer, gross margin, customer acquisition cost, and churn. These metrics reveal whether the software is sticky and profitable at the customer level. Monitor for new product announcements, customer wins (disclosed in press releases or SEC filings), and management changes—all of which signal strategic direction.

Search for independent reviews of Retrieve Dx/MDM and Retrieve Passport on healthcare IT forums and hospital IT publications. Clinician and IT leader opinions matter; they influence purchasing decisions. Look for research reports from firms tracking the healthcare software market (advisory firms like Gartner or Forrester publish rankings of clinical decision-support tools). Check whether hospitals that have adopted Retrieve Medical’s tools have published case studies or outcomes data—academic publications, health IT conferences—showing the clinical or financial impact.

Finally, monitor the broader regulatory environment. Changes in interoperability requirements, data-sharing rules, or EHR adoption drivers can accelerate or impede demand for specialized software like Retrieve’s. A shift toward value-based payment models (bundled payments, accountable care organisations) creates additional incentive for complete medical information and decision support, potentially broadening the addressable market. Conversely, consolidation among hospitals into large health systems favoring single-vendor strategies could marginalise niche software vendors. The company’s success or failure will be decided not only by its execution but by these wider shifts in healthcare infrastructure and regulation.